Oncogene publishes a study authored by NTNU Professor and APIM Therapeutics's CSO Marit Otterlei and co-workers. In the article entitled “PCNA regulates primary metabolism by scaffolding metabolic enzymes“, it was shown for the first time that Proliferating Nuclear Cell Antigen (PCNA) is a cytosolic scaffold protein important for regulating primary metabolism and thereby cellular signaling. This data support the phase 1 clinical results obtained with ATX-101, published back to back in the same issue of Oncogene. For more information on this article, please visit this link.
